Actinomycin Analogs From Streptomyces polyantibioticus S4D258: Structural Elucidation and Antiproliferative Activity Against Triple‐Negative Breast Cancer
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von He Pang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Engineering Technology Research Center for Innovative Drugs and Bioproducts, School of Pharmacy, Guangdong Medical University, D…. Hauptthemen laut MEDLINE: Streptomyces, Dactinomycin, Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Ordinary University Innovation Team Project of Guangdong Province, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Fifteen new actinomycin analogs were obtained from the marine‐derived Streptomyces polyantibioticus S4D258. Structural elucidation of these compounds was successfully achieved by comprehensive analysis of high‐resolution electrospray ionization mass spectrometry (HR‐ESIMS), nuclear magnetic resonance spectroscopy (NMR), and Marfey's method. Notably, actinomycins H 1 –H 5 ( 1 – 5 ) contain L ‐serine ( L ‐Ser), D ‐2‐aminobutyric acid ( D ‐2‐Aba), and L ‐2‐methylaminobutyric acid ( L ‐2‐MeAba) residues, whereas actinomycin H 6 ( 6 ) comprises a 5 H ‐oxazolo[4,5‐ b ]phenoxazine chromophore. Actinomycins H 7 –H 15 ( 7 – 15 ) are nine truncated actinomycin analogs only containing one pentapeptidolactone unit. Actinomycins H 1 ( 1 ) and H 9 ( 9 ) exhibited inhibitory activities against the proliferation of triple‐negative breast cancer MDA‐MB‐231 cells with IC50 values of 28.00 nM and 4.34 µM, respectively. Mechanistic investigation revealed that the above two actinomycin analogs not only induce S‐phase arrest, mitochondrial membrane potential depolarization, and apoptosis, but also trigger ferroptosis, as revealed by an increase in the level of reactive oxygen species, lipid peroxidation, and malondialdehyde. Collectively, our findings enriched the structural diversity of natural actinomycins and inspired the re‐examination of actinomycin analogs as anticancer leads against triple‐negative breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Engineering Technology Research Center for Innovative Drugs and Bioproducts, School of Pharmacy, Guangdong Medical University, Dongguan, P. R. China.
- Department of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia, Egypt.
- Dongguan Key Laboratory For Marine Innovative Drugs and Bioproducts, Guangdong Medical University, Dongguan, P. R. China.
ORCID-Profile: He Pang, Usama Ramadan Abdelmohsen, Li Shen, Jun Wu
Förderung
- National Natural Science Foundation of China
- Ordinary University Innovation Team Project of Guangdong Province
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Pang, H., Huang, X. M., Abdelmohsen, U. R., Shen, L., & Wu, J. (2026). Actinomycin Analogs From Streptomyces polyantibioticus S4D258: Structural Elucidation and Antiproliferative Activity Against Triple‐Negative Breast Cancer. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71791
Vancouver
Pang H, Huang XM, Abdelmohsen UR, Shen L, Wu J. Actinomycin Analogs From Streptomyces polyantibioticus S4D258: Structural Elucidation and Antiproliferative Activity Against Triple‐Negative Breast Cancer. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71791
BibTeX
@article{Pang2026,
author = {Pang, He and Huang, Xiao-Min and Abdelmohsen, Usama Ramadan and Shen, Li and Wu, Jun},
title = {Actinomycin Analogs From Streptomyces polyantibioticus S4D258: Structural Elucidation and Antiproliferative Activity Against Triple‐Negative Breast Cancer},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71791}
}
EUVIMED